-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
RSV-IN-6
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2415152-41-7.gif)
| Category | Respiratory syncytial Virus (RSV) |
| CAS | 2415152-41-7 |
| Description | RSV-IN-6 (Compound 53) is an anti-RSV agent targeting M2-1 protein with EC50 values of 4.4 μM and 1.3 μM against RSV-A and RSV-B strain, respectively. |
Product Information
| Synonyms | RSV-IN-6|CHEMBL4644024|HY-150547|CS-0534434 |
| Molecular Weight | 85.57 |
| Molecular Formula | C19H19N3S3 |
| Canonical SMILES | C1CN(CCN1C2=CC=CC=C2)C(=S)SCC3=NC4=CC=CC=C4S3 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 447 |
| Exact Mass | 385.07411114 |
| Target | EC50: 1.3 μM (RSV-B), 4.4 μM (RSV-A) |
| XLogP3-AA | 4.8 |
